The World’s First $1 Trillion Drug

Dear Reader,   It’s being called “a miracle.”  And the “holy grail of medicine.” That’s “widely expected to be one of the top-selling medicines in history.” They’re talking about new drugs called “GLP-1 agonists.” And everybody’s raving about them because they make weight loss easy.  No diet and no exercise required. It’s a dream come true for dieters. Which is why some Wall Street analysts are predicting these drugs will generate $200 billion annually by 2030.  That’s more revenue than the current top-10 selling medicines generate… combined. But former hedge fund manager Ian King says Wall Street is WRONG. Because of one line he found in this official FDA document, he says Wall Street is vastly UNDERESTIMATING the potential.  Instead… Ian predicts this could become the world’s first trillion-dollar drug. And he’s recommending 3 little-known stocks to play this fast-moving trend.    Click here for all the details.        Regards,     Sarah Williams Associate Editorial Manager, Banyan Hill Publishing   P.S. This is a time-sensitive opportunity. Because of what Ian found in this FDA document, he believes the FDA could make a major announcement about GLP-1 drugs within the next 6 months. If that happens, he says the share prices of the 3 little-known stocks he’s recommending could skyrocket.      This ad is sent on behalf of Banyan Hill Publishing. P.O. Box 8378, Delray Beach, FL 33482.  If you would like to unsubscribe from receiving offers for Strategic Fortunes, please click here.